Diego Pellicer Worldwide (DPWW) 10-Q 20 Nov 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Nov. 19, 2020
Document And Entity Information
Entity Registrant Name	DIEGO PELLICER WORLDWIDE, INC
Entity Central Index Key	0001559172
Document Type	10-Q
Document Period End Date	Sep. 30, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity's Reporting Status Current	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Shell Company	false
Entity File Number	000-54530
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	DE
Entity Common Stock, Shares Outstanding		198,432,057
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2020

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 390,195	$ 317,446
Accounts receivable	498,630	391,273
Prepaid expenses		12,111
Total current assets	888,825	720,830
Other receivables	753,331	788,177
Security deposits	150,000	150,000
Right of Use Assets	2,500,964	3,009,163
Total assets	4,293,120	4,668,170
Current liabilities:
Accounts payable	500,823	514,196
Accrued payable - related party	1,351,408	1,293,238
Accrued expenses	826,246	587,707
Notes payable - related party	140,958	140,958
Notes payable	339,847	133,403
Convertible notes, net of discount and costs	3,208,474	2,352,530
Derivative liabilities	4,078,297	5,024,321
Lease Liabilities	677,689	676,336
Warrant liabilities	633	967
Total current liabilities	11,124,375	10,723,656
Lease Liabilities	1,792,687	2,299,152
Total liabilities	12,917,061	13,022,808
Redeemable convertible preferred stock, Series C	15,502	8,750
Deficiency in stockholders' equity:
Preferred stock, Series A and B, par value $.0001 per share; 5,000,000 shares authorized, none issued and outstanding
Common stock, par value $.000001 per share; 840,000,000 shares authorized, 164,591,275 and 113,926,332 shares issued, respectively	160	114
Additional paid-in capital	44,209,527	43,478,139
Stock to be issued	238,947	127,261
Accumulated deficit	(53,088,078)	(51,968,902)
Total deficiency in stockholders' equity	(8,639,444)	(8,363,388)
Total liabilities and deficiency in stockholders' equity	$ 4,293,120	$ 4,668,170

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Common stock, par value	$ 0.000001	$ 0.000001
Common stock, shares authorized	840,000,000	840,000,000
Common stock, shares issued	164,591,275	113,926,332
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Series B Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Redeemable Convertible Preferred Stock Series C [Member]
Preferred stock, par value	$ .00001	$ .00001
Preferred stock, shares authorized	1,500,000	1,500,000
Preferred stock, shares issued	55,800	140,000
Preferred stock, shares outstanding	55,800	140,000
Discount	$ 40,298	$ 131,250

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenues
Net rental revenue	$ 351,502	$ 388,218	$ 1,080,382	$ 1,257,255
Rental expense	(283,916)	(280,613)	(857,535)	(858,136)
Gross profit	67,586	107,605	222,847	399,119
Operating expenses:
General and administrative expenses	356,305	349,608	885,960	1,272,086
Selling expense	9,552	12,269	24,593	42,406
Depreciation expense				139,595
Loss from Operations	(298,271)	(254,272)	(687,706)	(1,054,968)
Other income (expense)
Other income (expense)	44,118	145	109,897	217
Interest expense	(207,427)	(856,017)	(1,502,058)	(2,468,228)
Gain on sale of lease				534,649
Extinguishment of debt	(677)	88,063	1,255	218,196
Change in derivative liabilities	(372,217)	2,467,245	1,095,821	1,873,119
Change in value of warrants	362	1,038	334	15,114
Total other income (loss), net	(535,841)	1,700,474	(294,751)	173,067
Provision for taxes
Net income (loss)	(834,112)	1,446,202	(759,610)	(881,901)
Accrued dividends and accretion of conversion feature	(20,832)		(80,545)
Deemed dividend on preferred stock	14,740		(56,156)
Net income (loss) available to common shareholders	$ (840,204)	$ 1,446,202	$ (896,311)	$ (881,901)
Income (loss) per share - basic	$ 0	$ 0.02	$ 0	$ (0.02)
Income (loss) per share - diluted	$ 0	$ 0	$ 0	$ (0.02)
Weighted average common shares outstanding - basic	150,791,163	63,999,272	136,131,006	50,426,491
Weighted average common shares outstanding - diluted	150,791,163	546,632,422	136,131,006	50,426,491

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Redeemable Convertible Preferred Stock Series C [Member]	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Common Stock To Be Issued	Total
Balance, beginning at Dec. 31, 2018		$ 28	$ 40,405,703	$ (49,354,030)	$ 710,838	$ (8,264,191)
Balance, beginning, shares at Dec. 31, 2018		28,287,414
Issuance of common shares for services		$ 5	398,452		(312,839)	85,618
Issuance of common shares for services, shares		4,475,943
Issuance of common shares for services - related parties		$ 7	455,250		84,699	539,956
Issuance of common shares for services - related parties, shares		7,244,637
Fair value of warrants and options granted for services			(108,121)		108,121
Fair value of warrants and options granted for services, shares		(675,759)
Common stock issued upon conversion of notes payable		$ 37	1,411,188		(133,018)	1,278,207
Common stock issued upon conversion of notes payable, shares		36,938,746
Grants and options granted for services			121,786			81,190
Net loss				(881,901)		(881,901)
Balance, ending at Sep. 30, 2019		$ 77	42,684,258	(50,235,931)	475,801	(7,120,525)
Balance, ending, shares at Sep. 30, 2019		76,270,981
Balance, beginning at Jun. 30, 2019		$ 55	42,253,745	(51,682,133)	444,973	(9,010,090)
Balance, beginning, shares at Jun. 30, 2019		54,504,872
Issuance of common shares for services		$ 1	25,327		(1,993)	23,335
Issuance of common shares for services, shares		1,478,693
Issuance of common shares for services - related parties		$ 4	81,196		(42,000)	39,200
Issuance of common shares for services - related parties, shares		3,632,972
Fair value of warrants and options granted for services			40,596			40,596
Fair value of warrants and options granted for services, shares
Common stock issued upon conversion of notes payable		$ 17	283,394		56,821	340,232
Common stock issued upon conversion of notes payable, shares		16,654,444
Shares cancelled for convertible note
Shares cancelled for convertible note, shares
Net loss				1,446,202		1,446,202
Balance, ending at Sep. 30, 2019		$ 77	42,684,258	(50,235,931)	475,801	(7,120,525)
Balance, ending, shares at Sep. 30, 2019		76,270,981
Balance, beginning at Dec. 31, 2019	$ 8,750	$ 114	43,478,139	(51,968,902)	127,261	(8,363,388)
Balance, beginning, shares at Dec. 31, 2019	140,000	113,926,332
Issuance of common shares for services		$ 2	25,598		37,803	63,403
Issuance of common shares for services, shares		2,000,000
Issuance of common shares for services - related parties		$ 3	65,630		26,296	91,929
Issuance of common shares for services - related parties, shares		2,553,969
Fair value of warrants and options granted for services			121,785			121,785
Fair value of warrants and options granted for services, shares
Common stock issued upon conversion of notes payable		$ 14	169,723		47,587	217,324
Common stock issued upon conversion of notes payable, shares		13,767,631
Series C preferred stock converted to common stock	$ (73,793)	$ 27	$ 348,653			$ 348,681
Series C preferred stock converted to common stock, shares	(195,800)	32,343,343
Series C preferred stock issued for cash, net of costs and discounts
Series C preferred stock issued for cash, net of costs and discounts, Shares	111,600
Accrued dividends and accretion of conversion feature on Series A preferred stock	$ 80,545			$ (80,545)		$ (80,545)
Deemed dividends related to conversion feature of Series C preferred stock				(56,156)		(56,156)
Net loss				(982,476)		(969,808)
Balance, ending at Sep. 30, 2020	$ 15,502	$ 160	44,209,527	(53,088,078)	$ 238,947	(8,639,444)
Balance, ending, shares at Sep. 30, 2020	55,800	164,591,275
Balance, beginning at Jun. 30, 2020	$ 56,287	$ 131	43,881,123	(52,247,878)	119,668	(8,246,951)
Balance, beginning, shares at Jun. 30, 2020	212,552	135,187,691
Issuance of common shares for services		$ 2	25,598		25,600	51,200
Issuance of common shares for services, shares		2,000,000
Issuance of common shares for services - related parties					46,092	46,092
Issuance of common shares for services - related parties, shares
Fair value of warrants and options granted for services			40,591			40,591
Fair value of warrants and options granted for services, shares
Common stock issued upon conversion of notes payable					47,587	47,587
Common stock issued upon conversion of notes payable, shares
Conversion of preferred shares into common shares	$ (61,617)	$ 27	$ 262,215			$ 262,242
Conversion of preferred share into common shares, shares	(156,752)	27,403,584
Series C preferred stock issued for cash, net of costs and discounts
Series C preferred stock issued for cash, net of costs and discounts, Shares
Accrued dividends and accretion of conversion feature on Series A preferred stock	$ 20,832			$ (20,832)		$ (20,832)
Deemed dividends related to conversion feature of Series C preferred stock				14,740		14,740
Net loss				(834,108)		(834,108)
Balance, ending at Sep. 30, 2020	$ 15,502	$ 160	$ 44,209,527	$ (53,088,078)	$ 238,947	$ (8,639,444)
Balance, ending, shares at Sep. 30, 2020	55,800	164,591,275

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOW (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income (loss)	$ (982,476)	$ (881,901)
Adjustments to reconcile cash used in operations to net
Depreciation		139,595
Change in fair value of derivative liability	(1,095,821)	(1,873,119)
Change in value of warrants	(334)	(15,114)
Amortization of debt related cost	942,601	2,203,630
Gain related to additional derivative liability	299,783
Extinguishment of debt	(1,255)	(218,196)
Stock based compensation	213,714	697,358
Common Stock payable issued for services	63,403
Changes in operating assets and liabilities:
Accounts receivable	(107,357)	(172,866)
Prepaid expenses	12,111	48,670
Other Assets	(315,152)	(247,847)
Other current receivable - related parties	300,000	(38,655)
Other current receivable - related parties	50,000	49,922
Accounts payable	(13,372)	(38,655)
Accrued liability - related parties	58,170	49,922
Accrued expenses	246,705	195,423
Lease liabilities	3,085	(240,310)
Contingent liabilities		(71,110)
Cash used in operating activities	(326,195)	(424,519)
Cash flows from financing activities:
Debt costs		(16,225)
Proceeds from notes payable	206,444
Proceeds from convertible notes payable	100,000	862,725
Repayments of convertible notes payable, net	(7,500)	(120,500)
Proceeds from sale of preferred stock	100,000
Cash provided by financing activities	398,944	726,000
Net increase (decrease) in cash	72,749	301,481
Cash, beginning of period	317,446	60,437
Cash, end of period	390,195	361,918
Cash paid for interest
Cash paid for taxes
Supplemental schedule of noncash financial activities:
Notes converted to stock	119,000	767,533
Discount related to convertible notes and Preferred C shares	(200,000)
Accrued interest converted to stock	8,166	47,165
Value of derivative liability extinguished upon conversion and pay off of notes and accrued interest	128,582	891,922
Value of derivative liability extinguished upon conversion and pay off of preferred stock	276,445
Accounts payable and accrued expenses paid with common stock		50,000
Debt issuance costs deducted from proceeds of notes		16,225
Debt discount extinguished from note conversion	39,843
Conversion of Preferred Stock for Common Stock	73,793
Accrued dividends and accretion of conversion feature on Series C preferred stock	80,545
Deemed dividends related to conversion feature of Series C preferred stock	$ 56,156

Organization and Operations

Organization and Operations	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Operations	Note 1 – Organization and Operations History On March 13, 2015, Diego Pellicer Worldwide, Inc. (the Company) (f/k/a Type 1 Media, Inc.) closed on a merger and share exchange agreement by and among (i) the Company, and (ii) Diego Pellicer World-wide 1, Inc., a Delaware corporation, (“Diego”), and (iii) Jonathan White, the majority shareholder of the Company. Diego was merged with and into the Company with the Company to continue as the surviving corporation in the merger. The Company succeeded to and assumed all the rights, assets, liabilities, debts, and obligations of Diego. Prior to the merger, 3,135,000 shares of Type 1 Media, Inc. were issued and outstanding. The principal owners of the Company agreed to transfer their 2,750,000 issued and outstanding shares to a third party in consideration for $169,000 and cancellation of their 2,750,000 shares. The remaining issued and outstanding shares are still available for trading in the marketplace. At the time of the merger, Type 1 Media, Inc. had no assets or liabilities. Accordingly, the business conducted by Type 1 prior to the merger is not being operated by the combined entity post-merger. At the closing of the merger, Diego common stock issued and outstanding immediately prior to the closing of the merger was exchanged for the right to receive one share of the surviving corporation for each share of Diego. An aggregate of 1,081,613 common shares of the surviving corporation were issued to the holders of Diego in exchange for their common shares representing approximately 74% of the combined entity. The merger has been accounted for as a reverse merger and recapitalization in which Diego is treated as the accounting acquirer and Diego Pellicer Worldwide, Inc. is the surviving corporation. Business Operations The Company leases real estate to licensed marijuana operators providing complete turnkey growing space, processing space, recreational and medical retail sales space and related facilities to licensed marijuana growers, processors, dispensary and recreational store operators. Additionally, the Company plans to explore ancillary opportunities in the regulated marijuana industry as well as offering for wholesale distribution branded non-marijuana clothing and accessories. The properties generating rents in 2019 and 2020 are as follows: Purpose Size City State Retail store (recreational and medical) 3,300 sq. Denver CO Cultivation warehouse 18,600 sq. Denver CO Cultivation warehouse 14,800 sq. Denver CO Retail store (recreational and medical) - Sold in May 2019 4,500 sq. Seattle WA The Company’s three properties in Denver, CO are leased to Royal Asset Management, LLC (“Royal Asset Management”). Royal Asset Management opened the Diego Denver branded flagship store in February 2017. This store known as “Diego Colorado”. The retail facilities have shown steady growth in sales since opening. For the other two properties subleased, Royal Asset Management uses these properties for its cultivation facilities in Denver, CO. Production at these facilities began in late 2016. The Company is currently exploring the acquisition of this entity, and the parties are in negotiation. In October 2020, the master and sublease associated with the 18,600 sq. Cultivation warehouse in Denver were terminated. In regards to the Seattle property, on May 6, 2019, the Company entered into an agreement with a third party, and sold the Seattle leased location. The sale provided $550,000 in capital and executive resources for expansion which the company allocated to its efforts in a new location and cannabis grow facilities in Colorado.

Significant and Critical Accoun

Significant and Critical Accounting Policies and Practices	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Significant and Critical Accounting Policies and Practices	Note 2 - Significant and Critical Accounting Policies and Practices The management of the Company is responsible for the selection and use of appropriate accounting policies and the appropriateness of accounting policies and their application. Critical accounting policies and practices are those that are both most important to the portrayal of the Company’s financial condition and results and require management’s most difficult, subjective, or complex judgments, often because of the need to make estimates about the effects of matters that are inherently uncertain. The Company’s significant and critical accounting policies and practices are disclosed below as required by generally accepted accounting principles. Basis of Presentation The accompanying consolidated financial statements and related notes have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and presented in accordance with accounting principles generally accepted in the United States of America (US GAAP). The accompanying consolidated balance sheet at December 31, 2019, has been derived from audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying unaudited condensed consolidated financial statements as of September 30, 2020 and for the nine months ended September 30, 2020 and 2019, have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements, and should be read in conjunction with the audited consolidated financial statements and related notes to the financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 as filed with the U.S. Securities and Exchange Commission (“SEC”) on the opinion of management, all material adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been made to the condensed consolidated financial statements. The condensed consolidated financial statements include all material adjustments (consisting of normal recurring accruals) necessary to make the condensed consolidated financial statements not misleading as required by Regulation S-X Rule 10-01. Operating results for the nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020 or any future periods. Principles of Consolidation The financial statements include the accounts of Diego Pellicer Worldwide, Inc., and its wholly-owned subsidiary Diego Pellicer World-wide 1, Inc. Intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include valuing equity securities and derivative financial instruments issued in financing transactions and share based payment arrangements, the collectability of accounts receivable and other receivables (See Note 5), valuation of right of use assets and lease liabilities and deferred taxes and related valuation allowances. Certain estimates, including evaluating the collectability of accounts receivable, could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could influence our estimates that could cause actual results to differ from our estimates. The Company intends to re-evaluate all its accounting estimates at least quarterly based on these conditions and record adjustments when necessary. Fair Value Measurements The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. Fair Value of Financial Instruments As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of September 30, 2020 and December 31, 2019. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash, prepaid expenses and accounts payable. Fair values were assumed to approximate carrying values for cash and payables because they are short term in nature and their carrying amounts approximate fair values or they are payable on demand. The following table reflects assets and liabilities that are measured at fair value on a recurring basis (in thousands): As of September 30, 2020 Fair Value Measurement Using Level 1 Level 2 Level 3 Total Derivative liabilities $ — $ — $ 4,078 $ 4,078 Stock warrant liabilities — — 1 1 $ — $ — $ 4,786 $ 4,786 As of December 31, 2019 Fair Value Measurement Using Level 1 Level 2 Level 3 Total Derivative Liabilities $ — $ — $ 5,024 $ 5,024 Stock warrant Liabilities — — 1 1 $ — $ — $ 5,025 $ 5,025 Derivative liabilities and stock warrant liabilities were valued using the Binomial Option Pricing Model in calculating the embedded conversion features for the nine months ended September 30, 2020 and the year ended December 31, 2019. Cash The Company maintains cash balances at various financial institutions. Accounts at each institution are insured by the Federal Deposit Insurance Corporation, and the National Credit Union Share Insurance Fund, up to $250,000. The Company’s accounts at these institutions may, at times, exceed the federal insured limits. The Company has not experienced any losses in such accounts. Revenue recognition In accordance with ASC 842, Leases During the initial term of the lease, management has a policy of partial rent forbearance when the tenant first opens the facility to assure that the tenant has the opportunity for success. Management may be required to exercise considerable judgment in estimating revenue to be recognized. When management concludes that the Company is the owner of tenant improvements, management records the cost to construct the tenant improvements as a capital asset. In addition, management records the cost of certain tenant improvements paid for or reimbursed by tenants as capital assets when management concludes that the Company is the owner of such tenant improvements. For these tenant improvements, management records the amount funded or reimbursed by tenants as deferred revenue, which is amortized as additional rental income over the term of the related lease. When management concludes that the tenant is the owner of tenant improvements for accounting purposes, management records the Company’s contribution towards those improvements as a lease incentive, which is amortized as a reduction to rental revenue on a straight-line basis over the term of the lease. The Company has adopted the new revenue recognition guidelines in accordance with ASC 606, Revenue from Contracts with Customers Leases. The Company analyzes its contracts to assess that they are within the scope and in accordance with ASC 606. In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under each of its agreements, whether for goods and services or licensing, the Company performs the following steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations based on estimated selling prices; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation. Advertising During the nine months ended September 30, 2020 and 2019, advertising expense was $24,593 and $42,406, respectively. Income Taxes Income taxes are provided for using the liability method of accounting in accordance with the Income Taxes Topic of the FASB ASC. Deferred tax assets and liabilities are determined based on differences between the financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized and when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The computation of limitations relating to the amount of such tax assets, and the determination of appropriate valuation allowances relating to the realizing of such assets, are inherently complex and require the exercise of judgment. As additional information becomes available, the Company continually assesses the carrying value of their net deferred tax assets. Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide us a choice of net cash settlement or settlement in our own shares (physical settlement or net-share settlement) provided that such contracts are indexed to our own stock as defined in ASC Topic 815-40 “Contracts in Entity’s Own Equity.” The Company classifies as assets or liabilities any contracts that require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside our control or give the counterparty a choice of net-cash settlement or settlement in shares. The Company assesses classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required. Stock-Based Compensation The Company recognizes compensation expense for stock-based compensation in accordance with ASC Topic 718. The Company calculates the fair value of the award on the date of grant using the Black-Scholes method for stock options and the quoted price of our common stock for unrestricted shares; the expense is recognized over the service period for awards expected to vest. The estimation of stock-based awards that will ultimately vest requires judgment, and to the extent actual results or updated estimates differ from original estimates, such amounts are recorded as a cumulative adjustment in the period estimates are revised. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience. The adoption of new standard did not have a material impact on the Company’s Consolidated Financial Statements. Income (loss) per common share The Company utilizes ASC 260, “Earnings per Share” for calculating the basic and diluted loss per share. In accordance with ASC 260, the basic and diluted loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding. Diluted net loss per share is computed similar to basic loss per share except that the denominator is adjusted for the potential dilution that could occur if stock options, warrants, and other convertible securities were exercised or converted into common stock. Potentially dilutive securities are not included in the calculation of the diluted loss per share if their effect would be anti-dilutive. The Company has 1,129,526,612 and 533,059,641 common stock equivalents at September 30, 2020 and 2019, respectively. For the nine and three months ended September 30, 2020, the potential shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would reduce net loss per share. There are 840,000,000 shares authorized resulting in 289,076,612 insufficient shares as of September 30, 2020. Legal and regulatory environment The cannabis industry is subject to numerous laws and regulations of federal, state and local governments. These laws and regulations include, but are not limited to, matters such as licensure, accreditation, and different taxation between federal and state. Federal government activity may increase in the future with respect to companies involved in the cannabis industry concerning possible violations of federal statutes and regulations. Management believes that the Company is in compliance with local, state and federal regulations, while no regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation, as well as regulatory actions unknown or unasserted at this time.

Going Concern

Going Concern	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 3 - Going Concern The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred losses since inception, its current liabilities exceed its current assets by $ 10,235,550, and has an accumulated deficit of $53,088,078 at September 30, 2020. These factors raise substantial doubt about its ability to continue as a going concern over the next twelve months. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. There are future noncash charges in connection with financing such as a change in derivative liability that will affect income but have no effect on cash flow. Although the Company has been successful raising additional capital, there is no assurance that the company will sell additional shares of stock or borrow additional funds. The Company’s inability to raise additional cash could have a material adverse effect on its financial position, results of operations, and its ability to continue in existence. These financial statements do not include any adjustments that might result from the outcome of this uncertainty. Management believes that the Company’s future success is dependent upon its ability to achieve profitable operations, generate cash from operating activities and obtain additional financing. There is no assurance that the Company will be able to generate sufficient cash from operations, sell additional shares of stock or borrow additional funds. However, cash generated from lease revenues is currently exceeding lease costs, but is insufficient to cover operating expenses.

Property and Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2020
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 4 - Property and Equipment As of September 30, 2020 and December 31, 2019, fixed assets and the estimated lives used in the computation of depreciation are as follows: Estimated Useful September 30, December 31, Lives 2020 2019 Leasehold improvements 10 years 515,450 515,450 Less: Accumulated depreciation and amortization (515,450 ) (515,450 ) Property and equipment, net $ — $ — During the nine months ended September 30, 2020 and 2019, the Company recorded depreciation expense of $0 and $139,595, respectively.

Accounts Receivables and Other

Accounts Receivables and Other Receivables	9 Months Ended
	Sep. 30, 2020
Notes to Financial Statements
Accounts Receivables and Other Receivables	Note 5 – Accounts Receivables and Other Receivables As disclosed in Note 1, the Company subleases three properties in Colorado to Royal Asset Management. At September 30, 2020, the Company had outstanding receivables from the subleases totaling $498,630, and during the three months ended September 30, 2020, the Company’s subleases with Royal Asset Management accounted for 100% of the Company’s revenues. In addition to the receivables from the subleases, the Company has agreed to provide Royal Asset Management and affiliates of Royal Asset Management up to aggregate amount of $1,030,000 in financing. These notes accrue interest at the rates ranging from 12% to 18% per annum. As of September 30, 2020 and December 31, 2019, the outstanding balance of these notes receivable total $753,331 and $788,177, respectively, including accrued interest of $252,047 and $153,509. The amount presented in our balance sheet is $755,331 and $788,177, which represents the $982,047 and $1,017,143 due to us, less $228,966 and $228,966 that we owe to Royal Asset Management for leasehold improvements. The notes are secured by a UCC filing and also $400,000 of the balance is personally guaranteed by the managing member of Royal Asset Management. During the nine months ended September 30, 2020, we loaned an additional net $204,448 under these contracts. If we do acquire Royal Asset Management, part of the purchase price will be paid through receivables that are owed to us. On September 9, 2020, Diego Pellicer Worldwide, Inc. (“Registrant”) closed on a Membership Interest Purchase Agreement dated September 4, 2020, and obtained the right to acquire a 15.13% membership interest in Blue Bronco, LLC. The purchase of the 15.13% interest in Blue LLC, is subject to the approval of the Colorado Marijuana Enforcement Division. Necessary approval by governing authorities is expected to be received in Q4 2020. As part of these transactions, Registrant received full payment of E2T2, LLC’s promissory note receivable, dated November 1, 2018, in the principal amount of $300,000, made by E2T2, LLC, as maker, and Registrant, as payee, as well as full payment of its outstanding promissory note receivable, dated February 27, 2020, in the principal amount of $50,000. Upon receipt of this payment of $50,000 plus accrued interest, Registrant made a payment of $34,264.84 to E2T2, LLC in order to “true up” its obligations under that certain E2T2, LLC promissory note, dated July 25, 2019, in the principal amount of $400,000 made in favor of Registrant.

Other Assets

Other Assets	9 Months Ended
	Sep. 30, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Assets	Note 6 – Other Assets Security deposits:

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
Related Party Transactions	Note 7 – Related Party Transactions As of September 30, 2020 and December 31, 2019, the Company has accrued compensation to CEO, CFO and Director in the amount of $280,097, and $155,841, respectively, of which $94,060 and $5,245 are included in stock payable. As of September 30, 2020 and December 31, 2019, accrued payables due to former officers were $1,071,311 and $1,137,397. For the three months ended September 30, 2020 and September 30, 2019, total cash-based compensation to related parties was $90,000 and $122,099 respectively. For the nine months ended September 30, 2020 and 2019, total cash-based compensation to related parties was $270,000 and $379,597, respectively. For the three months ended September 30, 2020 and September 30, 2019, total share-based compensation to related parties was $86,687 and $136,616, respectively. For the nine months ended September 30, 2020 and 2019, total share-based compensation to related parties was $213,714 and $661,742 respectively. These amounts are included in general and administrative expenses in the accompanying financial statements. From 2017 to 2019, Mr . Gonfiantini, CEO, personally and through his Company, Crystal Bay Financial LLC, loaned an aggregate amount of $1,020,000 to Royal Asset Management. These notes accrue interest at 17%-18% per annum, and require monthly payment approximately from $5,000 to $20,000. These notes are personally guaranteed by the managing member of Royal Asset Management, and secured by certain equipment and other tangible properties of Royal Asset Management. Among these notes, $500,000 note was also secured by the medical marijuana licenses held by Royal Asset Management. At September 30, 2020, the Company owed Mr. Throgmartin, former CEO (See Note 11), $140,958 pursuant to a promissory note dated August 12, 2016. This note accrued interest at the rate of 8% per annum and was payable upon the earlier date of (i) the second anniversary date of the promissory notes, (ii) the date all of the current investor notes, in the outstanding aggregate principal and accrued interest amount of approximately $1,480,000 at September 30, 2016, have been paid in full and the Company has achieved gross revenues of at least $3,000,000 over any consecutive 12-month period. The balance of related party note was $140,958 and $140,958 at September 30, 2020 and December 31, 2019, respectively. As of September 30, 2020, the note was past the maturity date, however the Company has not yet received a default notice.

Notes Payable

Notes Payable	9 Months Ended
	Sep. 30, 2020
Notes Payable [Abstract]
Notes Payable	Note 8 – Notes Payable On August 31, 2015, the Company issued a note in the amount of $126,000 with third parties for use as operating capital. The note was amended to include accrued interest on October 31, 2016 and extended the maturity date to October 31, 2018. As of September 30, 2020 and December 31, 2019 the outstanding principal balance of the note was $133,403. As of September 30, 2020, the note was past the maturity date, however the Company has not yet received a default notice. On April 22, 2020, the Company was granted a loan from Numerica Credit Union, in the aggregate amount of $56,444, pursuant to the Paycheck Protection Program, (the “PPP”) under Division A, Title I of the CARES Act, which was enacted March 27, 2020. The loan, which was in the form of a note dated April 22, 2020 issued by the Borrower, matures on April 22, 2022 and bears interest at a rate of 1.0% per annum, payable monthly commencing October 22, 2020. There have not been any payments made towards this loan, as the full amount of the loan expects to be forgiven when the company applies for forgiveness. Application for loan forgiveness is due ten months from the last day of the twenty-four week window that the company has to spend the money from the disbursement date of the loan on April 22, 2020. The loan may be prepaid by the Borrower at any time prior to maturity with no prepayment penalty. Funds from the Loan may only be used for payroll costs, costs used to continue group health care benefits, mortgage payments, rent, utilities, and interest on other debt obligations incurred before February 15, 2020. The Company used the entire Loan amount for qualifying expenses. Under the terms of the PPP, certain amounts of the Loan may be forgiven if they are used for qualifying expenses as described in the CARES Act. On June 30, 2020, the Company was granted a loan from the Small Business Association, in the aggregate amount of $150,000, pursuant to the Economic Injury Disaster Loan, (the “EIDL”) under Division A, Title I of the CARES Act, which was enacted March 27, 2020. The Company received the net funds of $149,900 on July 2, 2020. The loan, which was in the form of a note dated June 30, 2020 issued by the Borrower, matures on June 30, 2050 and bears interest at a rate of 3.75% per annum, payable monthly commencing June 30, 2021. The loan may be prepaid by the Borrower at any time prior to maturity with no prepayment penalty. Funds from the Loan may be used solely for working capital to alleviate economic injury caused by disaster occurring in the month of January 31, 2020 and continuing thereafter and to pay Uniform Commercial Code (UCC) lien filing fees and a third-party UCC handling charge of $100 which will be deducted from the loan amount stated above. The Company intends to use the entire Loan amount for qualifying expenses.

Convertible Notes Payable

Convertible Notes Payable	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Convertible Notes Payable	Note 9 – Convertible Notes Payable The Company has issued several convertible notes which are outstanding. The note holders shall have the right to convert principal and accrued interest outstanding into shares of common stock at a discounted price to the market price of our common stock. The conversion feature was recognized as an embedded derivative and was valued using a Binomial Option Pricing Model that resulted in a derivative liability of $4,015,091, and $4,834,190 at September 30, 2020 and December 31, 2019, respectively. All notes accrue interest ranging from 8% to 12% and will mature in 2020. In connection with the issuance of certain of these notes, the Company also issued warrants to purchase its common stock. Several convertible note holders elected to convert their notes to common stock during the nine months ended September 30, 2020, and the nine months ended September 30, 2019. The tables below provides the note payable activity for the nine months ended September 30, 2020, and the nine months ended September 30, 2019, and also a reconciliation of the beginning and ending balances for the derivative liabilities measured using fair significant unobservable inputs (Level 3) for the nine months ended September 30, 2020 and for the nine months ended September 30, 2019: Convertible Notes Discount Convertible Notes, Net of Discount Derivative Liabilities Balance, December 31, 2019 $ 3,266,775 $ 914,239 $ 2,352,530 $ 4,834,190 Issuance of convertible notes 103,000 103,000 — 394,001 Conversion of convertible notes (119,000 ) (39,843 ) (79,157 ) (128,583 ) Repayment of convertible notes (7,500 ) — (7,500 ) — Change in fair value of derivatives — — — (1,084,517 ) Amortization — (942,602 ) 942,601 — Balance September 30, 2020 $ 3,243,275 $ 34,794 $ 3,208,474 $ 4,015,091 Convertible Notes Discount Convertible Notes, Net of Discount Derivative Liabilities Balance, December 31, 2018 $ 3,324,487 $ 2,151,167 $ 1,173,319 $ 6,000,830 Issuance of convertible notes 870,500 886,725 (16,225 ) 1,656,840 Conversion of convertible notes (767,533 ) (210,217 ) (557,316 ) (835,725 ) Repayment of convertible notes (122,500 ) — (120,500 ) (56,197 ) Change in fair value of derivatives — — — (1,873,119 ) Amortization — (1,409,516 ) 1,409,516 — Balance September 30, 2019 $ 3,306,954 $ 1,418,159 $ 1,888,795 $ 4,892,629 During the nine months ended September 30, 2020, the Company entered into a convertible note in an aggregate amount of $103,000 which is a twelve months maturity, bearing 12% interest per annum. The note is convertible at 35% discount to the average of the two lowest Volume Weighted Average Prices (VWAPs) during the previous ten (10) trading days to the date of a Conversion Notice. This note was partially converted to common stock in the amount of $30,000 on September 28, 2020 along with accrued interest in the amount of $2,042, for a total of 5,733,397 shares converted. A loss on extinguishment of debt of $1,884, extinguishment of debt discount of $14,466 and reduction of derivative liabilities of $25,485 have been recorded related to this conversions The remaining balance on this convertible loan is $73,000 at the end of the quarter, with accrued interest of $4,968. The conversion features related were determined in the amount of $60,362 using Binomial Option Pricing Model. During the nine months ended September 30, 2020, $7,500 of note principal and $819 of accrued interest were repaid to a debt holder. During the nine months ended September 30, 2020, $89,000 of notes unrelated to the above mentioned $30,000 conversion, $6,282 of accrued interest and $210 additional fee was converted into 13,767,631 shares of common stock. A loss on extinguishment of debt of $1,931, extinguishment of debt discount of $25,377 and reduction of derivative liabilities of $97,838 have been recorded related to these conversions. As of September 30, 2020, several convertible notes in aggregate principal of $3,175,275 were past their maturity dates, however the Company has not yet received a default notice. No default or penalty was paid or required to be paid. On July 17, 2018, the Company entered into a certain Equity and Debt Restructure Agreement with two, long-time investors in the Company (the “Restructure Agreement”). Pursuant to the material terms of the Restructure Agreement, the investors agreed to return and cancel their collective 2,774,093 restricted Company common shares, which had been received from the prior conversion of their older convertible notes, in exchange for the Company’s issue to them recast convertible promissory notes. Accordingly, on the same date, these investors were each issued a First Priority Secured Promissory Note (the “Note” or “Notes”), in the principal amount of $1,683,558 and $545,607, respectively. In connection with this transaction, one of these investors agreed to loan the Company an additional $700,000. In 2018, the Company has received $220,000 cash proceeds of the additional $700,000 loan. Fair value of 2,774,093 restricted Company common shares were determined in the amount of $443,855 using market price and fair value of the embedded conversion feature were determined in the amount of $3,555,888 using Black Sholes Merton Option Model. As the result of the transaction, the Company recorded $2,892,033 in financing costs, and $2,449,275 as debt discount during year ended December 31, 2018. On March 29, 2019, the Company received $100,000 cash proceeds from the additional $700,000 loan. The conversion feature related to $100,000 were determined in the amount of $154,861 using Binomial Option Pricing Model. During year ended December 31, 2019, the Company received $380,000 cash proceeds from the additional $700,000 loan. The conversion feature related to $380,0000 were determined in the amount of $586,710 using Binomial Option Pricing Model. During the year ended December 31, 2019, we recorded $206,710 loss related to financing costs and $380,000 as debt discount. The following assumptions were used in the Binomial Option Pricing Model in calculating the embedded conversion features and related fair values for the nine months ended September 30, 2020 and 2019. September 30, September 30, Risk-free interest rates 0.10-0.11% 1.92% Expected life (years) 0.25 – 0.50 0.08 – 1.25 Expected dividends 0% 0% Expected volatility 147 - 165% 70 - 557%

Stockholder's Equity (Deficit)

Stockholder's Equity (Deficit)	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Stockholder's Equity (Deficit)	Note 10 – Stockholders’ Equity (Deficit) Series C Preferred Stock On December 16, 2019, Diego Pellicer Worldwide sold 140,000 of its Series C Convertible Preferred Shares, with an annual accruing dividend of 10%, to Geneva Roth Remark Holdings, Inc. (“Geneva”), for $130,000 pursuant to a Series C Preferred Purchase Agreement with Geneva. To accommodate this transaction, Registrant’s Board of Directors approved and filed a certain Certificate of Designations with the Secretary of State of Delaware, designating 1,500,000 of its available preferred shares as Series C Preferred Convertible Stock, Stated Value of $1.00 per share, and with a par value of $0.0001 per share. This Certificate of Designations provides Registrant with the opportunity to redeem the Series C Shares at various increased prices at time intervals up to the 6-month anniversary of the closing and mandates full redemption on the 24-month anniversary. Geneva may convert the Series C Shares into Registrant’s common shares, commencing on the 6-month anniversary of the closing at a 30% discount to the public market price. The Company recorded a derivative liability of $165,218, valued using a Binomial Option Pricing Model, associated with Series C Preferred Shares. On December 31, 2019, the fair value of the conversion feature was a derivative liability of $190,131, valued using a Binomial Option Pricing Model, associated with Series C Preferred Shares. The Series C Preferred Stock is classified as temporary equity due to that the shares are immediately convertible at the option of the note holder. During the year ended December 31, 2019, we recorded $8,750 accretion of discount. As of December 31, 2019, there were 140,000 shares outstanding and a discount of $131,250. For the nine months ended September 30, 2020, the company converted 140,000 shares of series C preferred stock along with related discount to 21,744,479 shares of Common Stock per the terms of the Agreement. As of September 30, 2020, there were 0 shares outstanding related to this issuance. On March 3, 2020, Diego Pellicer Worldwide sold 55,800 of its Series C Convertible Preferred Shares, with an annual accruing dividend of 10% to Geneva Roth Remark Holdings, Inc. (“Geneva”), for $50,000 pursuant to a Series C Preferred Purchase Agreement with Geneva. The Company recorded a derivative liability of $88,868 valued using a Binomial Option Pricing Model, associated with Series C Preferred Shares. During the nine months ended September 30, 2020, the company converted 55,800 shares of series C preferred stock along with related discount to 10,598,864 shares of Common Stock per the terms of the Agreement. As of September 30, 2020, there were 0 shares outstanding related to this issuance. On April 14, 2020, Diego Pellicer Worldwide sold 55,800 of its Series C Convertible Preferred Shares, with an annual accruing dividend of 10%, to Geneva Roth Remark Holdings, Inc. (“Geneva”), for $50,000 pursuant to a Series C Preferred Purchase Agreement with Geneva. The Company recorded a derivative liability of $82,028 valued using a Binomial Option Pricing Model, associated with Series C Preferred Shares. On September 30, 2020, the fair value of the conversion feature was a derivative liability of $63,206, valued using a Binomial Option Pricing Model, associated with Series C Preferred Shares. The Series C Preferred Stock is classified as temporary equity due to that the shares are immediately convertible at the option of the note holder. During the nine months ended September 30, 2020, we recorded $67,201 accretion of discount and $2,583 of accrued dividend. As of September 30, 2020, there were 55,800 shares outstanding and a discount of $42,882. Preferred Stock and Accrued Dividends Discount Preferred Stock and Accrued Dividends, Net of Discount Derivative Liabilities Balance, December 31, 2019 $ 140,000 $ 131,250 $ 8,750 $ 190,131 Issuance of Series C Preferred shares 111,600 111,600 — 170,896 Conversion of Series C Preferred shares and accrued dividend (206,561 ) (132,768 ) (73,793 ) (302,127 ) Accretion of conversion feature on Series C preferred stock 13,345 (67,200 ) 80,545 15,610 Change in fair value of derivatives — — — (11,304 ) Balance September 30, 2020 $ 58,324 $ 42,882 $ 15,502 $ 63,206 The following assumptions were used in the Binomial Option Pricing Model in calculating the embedded conversion features and current liabilities for the three months ended September 30, 2020 and the year ended December 31, 2019. September 30, September 30, Risk-free interest rates 0.12 – 0.14% 1.53 – 2.60% Expected life (years) 1.2 – 1.54 0.08 – 1.25 Expected dividends 0% 0% Expected volatility 171.7 – 180.1% 70 - 557% Common Shares During the nine months ended September 30, 2020, $119,000 of notes, $8,166 of accrued interest and $210 additional fee was converted into 19,501,028 shares of common stock. A gain on extinguishment of debt of $1,255, extinguishment of debt discount of $39,843 and reduction of derivative liabilities of $128,583 have been recorded related to these conversions. As of September 30, 2020, 5,733,397 shares were authorized, but not issued as of September 30, 2020. During the nine months ended September 30, 2020, 2,553,969 shares of common stock were issued for related party services valued at $65,633. These shares have been removed from shares to be issued as of September 30, 2020. As of September 30, 2020, 3,907,356 shares, valued at $28,296 for related party services, had not been issued. These were classified as shares to be issued at September 30, 2020. During the nine months ended September 30, 2020, 32,343,343 shares of common stock were issued as a result of the conversion of 195,800 shares of Series C Preferred shares. During the nine months ended September 30, 2020, 5,196,378 shares of common stock, valued at $63,403 for services, were authorized. 2,000,000 of the shares were issued during the nine months ended September 30, 2020. As of September 30, 2020, 3,196,378 shares, valued at $37,803 for services, had not issued. These were classified as shares to be issued at September 30, 2020. Common stock warrant activity: The Company has determined that certain of its warrants are subject to derivative accounting. The table below provides a reconciliation of the beginning and ending balances for the warrant liabilities measured using fair significant unobservable inputs (Level 3) for the nine months ended September 30, 2020: Balance at December 31, 2019 $ 967 Issuance of warrants — Change in fair value during period 334 Balance at September 30, 2020 $ 633 The following assumptions were used in calculations of the Binomial Option Pricing Model for the periods ended September 30, 2020 and the year ended December 31, 2019. September 30, December 31, Annual dividend yield 0% 0% Expected life (years) 0.17-7.13 0.42 – 8.13 Risk-free interest rate 0.11 – 0.55% 1.56 – 2.40% Expected volatility 234.4 - 239.7% 165 - 318% The following represents a summary of all common stock warrant activity: Number of Weighted Average Weighted Average Balance outstanding, December 31, 2019 211,826 $ 10.08 3.51 Expired (78,031 ) $ 30.00 - Balance outstanding, September 30, 2020 133,795 $ 10.08 3.22 Exercisable, September 30, 2020 133,795 $ 10.08 3.22 Common stock option activity: The Company maintains an Equity Incentive Plan pursuant of which 124,000 shares of Common Stock are reserved for issuance thereunder. This Plan was established to award certain founding members, who were instrumental in the development of the Company, as well as key employees, directors and consultants, and to promote the success of the Company’s business. The terms allow for each option to vest immediately, with a term no greater than 10 years from the date of grant, at an exercise price equal to par value at date of the grant. As of September 30, 2020, 88,750 shares had been granted, with 10,000 of those shares granted with warrants attached. There remain 35,250 shares available for future grants. During the nine months ended September 30, 2020 and 2019, the Company recorded total option expense of $121,785. Unamortized stock option expense at September 30, 2020 is $5,416, which will be charged to expense in remaining months of 2020. The aggregate intrinsic value of stock options outstanding at September 30, 2020 is $0. The following represents a summary of all common stock option activity: Number of Weighted Average Weighted Average Balance outstanding, December 31, 2019 172,479 $ 5.29 5.47 Granted — — Balance outstanding, September 30, 2020 172,479 $ 5.25 5.22 Exercisable, September 30, 2020 172,479 $ 5.25 5.22

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 11 – COMMITMENTS AND CONTINGENCIES Leases The Company leases property under operating leases. Property leases include retail and warehouse space with fixed rent payments and lease terms ranging from three to five years. The Company is obligated to pay the lessor for maintenance, real estate taxes, insurance and other operating expenses on certain property leases. These expenses are variable and are not included in the measurement of the lease asset or lease liability. These expenses are recognized as variable lease expense when incurred. The Company records the lease asset and lease liability at the present value of lease payments over the lease term. The leases typically do not provide an implicit rate; therefore, the Company uses its estimated incremental borrowing rate at the time of lease commencement to discount the present value of lease payments. The Company’s discount rate for operating leases at September 30, 2020 was 12%. Leases often include rental escalation clauses, renewal options and/or termination options that are factored into the determination of lease payments when appropriate. Lease expense is recognized on a straight-line basis over the lease term to the extent that collection is considered probable. As a result, the Company been recognizing rents as they become payable. Our weighted-average remaining lease term is 3.64 years. As of September 30, 2020, the maturities of operating leases liabilities are as follows (in thousands): Operating Leases 2020 remaining $ 241 2021 863 2022 719 2023 733 2024 445 2025 and beyond 45 Total 3,046 Less: amount representing interest (576 ) Present value of future minimum lease payments 2,470 Less: current obligations under leases 678 Long-term lease obligations $ 1,793 The Company has executed a series of agreements that will cancel the master lease on it Elizabeth street cannabis cultivation facility in Denver on October 21, 2020. It will allow the Company to reduce its liability exposure in the Elizabeth Street cultivation facility while securing deferred rents due and future sublet payments for 3 years and 9 months, valued at $1,325,443. In addition, a $120,000 deposit on the property is being returned to the Company. This is a disclosed subsequent event, see Note 13. Rent expense is recognized on a straight-line basis over the life of the lease. Rent expense consists of the following: Nine months ended September 30, Operating lease costs $ 508,199 Variable rent costs 349,336 Total rent expense $ 857,535 Other information related to leases is as follows: Nine months ended September 30, Other information: Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 118,577 Weighted-average remaining lease term - operating leases 3.64 yr Weighted-average discount rate - operating leases 12 % The Company recognized sublease income of $1,080,382 and $1,257,255 during the nine months ended September 30, 2020 and 2019, respectively. These three leases have three to five years terms with optional extension, expiration dates range from July 2021 to June 2025, and monthly base rent approximately $20,000-$40,000 plus variable triple net. As of September 30, 2020, the maturities of expected base sublease income are as follows (in thousands): Operating Leases Remaining of 2020 $ 328 2021 1,154 2022 930 2023 944 2024 588 2025 and beyond 58 Total $ 4,002 The Master Lease and Sublease Agreements of the property located at Elizabeth St in Colorado have been terminated as of October 21, 2020. The sublease income associated with that property, constituting approximately $2,139,000 of the above projected income for 2020 through 2025 and beyond. This is a disclosed subsequent event, see Note 13. Employment Agreements As a condition of their employment, the Board of Directors approved employment agreements with three key executives. These agreement provided that additional shares will be granted each year over the term of the agreement should their shares as a percentage of the total shares outstanding fall below prescribed ownership percentages. Nello Gofiniatini III, who became the Company’s CEO in October 2019 receives an annual grant of additional shares each year to maintain his ownership percentage at 10% of the outstanding stock. The Company’s CFO received a similar grant each to maintain his ownership percentage at 2% of the outstanding stock. In addition, prior to his departure in October 2019, Ron Throgmartin, the Company’s previous CEO, would receive a grant of additional shares to maintain his ownership at 7.5% of the Company’s outstanding stock. During the nine months ended September 30, 2020, the Company accrued compensation expense of approximately $92,034 on 6,461,325 shares of common stock under these agreements. During the year ended December 31, 2019, the Company accrued compensation expense of approximately $593,000 on 20,782,014 shares of common stock under these agreements. As of September 30, 2020 and December 31, 2019, the ending balance of accrued compensation was $60,022 and $79,817, respectively. During the three and nine months ending September 30, 2020 and 2019, the Company accrued compensation expenses as follows: Three Months ending September 30, Three Months ending September 30, Nine Months ending September 30, Nine Months ending September 30, Compensation $ 46,092 $ 224,941 $ 92,034 $ 539,957 Number of Shares 4,216,438 6,518,625 6,461,325 15,233,729 Departure of Executive Officer On January 30, 2019, the Company executed a Separation Agreement and Release with David Thompson, its former Senior Vice President- Finance, finalizing his departure from the Company as an employee. Pursuant to its material terms, the Company agreed to pay Mr. Thompson aggregate cash payments of $206,250 , based upon the Company’s receipt of certain gross sales receipts derived from its Alameda Store in Colorado, and certain stock grants based upon the Company’s outstanding common shares as of February 1, 2019, including a stock grant of 53,717 restricted common shares for accrued salary and 122,934 restricted common shares in exchange for his approximate 122,000 of stock options. During the three and nine months ended September 30, 2020, $13,452 and $21,086 was paid under this agreement, respectively. During the three and nine months ended September 30, 2019 no amounts were paid under this agreement. As of September 30, 2020 and December 31, 2019, the outstanding balance was $175,714 and $196,800, respectively, and is included in Accrued Payable – Related Party in the accompanying Consolidated Balance Sheet. On October 29, 2019, Diego Pellicer Worldwide, Inc. (“Registrant”) accepted the resignation of Ron Throgmartin from his positions as CEO, President and Director. Mr. Throgmartin’s resignation was not the result of any disagreements with Registrant’s plan of operations, policies or management. On the same date, Registrant appointed Christopher D. Strachan, Registrant’s Chief Financial Officer, to membership on Registrant’s Board of Directors and appointed Nello Gonfiatini III, Regiatrant’s Chief Operations Officer, to the additional post of Chief Executive Officer. Ron Throgmartin signed a 5-year term Separation Agreement which, among other matters, terminated his Employment Agreement, as amended. On the date of the Separation Agreement, the Company acknowledged it owed Mr. Throgmartin the amount of $517,252.06 in principal and accrued interest of note payable, salary and fees, accrued during the 5 years of his employment. In addition, the Corporation further acknowledged that it will pay Mr Throgmartin fifty (50%) percent of his compensation due under the remaining Employment Agreement, or $614,583.33 under certain condition, which the Company accrued in full as of the date of Mr Throgmartin’s separation. This agreement provides that the Registrant will pay him $5,000 monthly against his accrued salary/fees and 50% of future compensation due under his terminated Employment Agreement, with certain accelerated payments in the event Registrant’s financial results attain certain EBITA benchmarks. Registrant shall have the right to require Mr. Throgmartin to provide consulting services to Registrant for a per diem fee of $500. As of September 30, 2020 and December 31, 2019, the outstanding balance was $895,597 and $940,597, respectively.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 13 – Subsequent Events The Company evaluated subsequent events and transactions that occur after the balance sheet date up to the date that the consolidated financial statements are available to be issued. Any material events that occur between the balance sheet date and the date that the consolidated financial statements were available for issuance are disclosed as subsequent events, while the consolidated financial statements are adjusted to reflect any conditions that existed at the balance sheet date. Based upon this review, except as disclosed within the footnotes or as discussed below, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the consolidated financial statements. On October 1, 2020, the company issued 5,769,230 shares of common stock for the stock payable due to JSJ as of September 30, 2020. On October 12, 2020, the company converted $30,921.59 of the JSJ Convertible Note into 8,345,908 shares of common stock. On October 14, 2020, the company converted 15,000 shares of series C preferred stock into 3,841,463 shares of common stock. On October 21, 2020, the company converted 17,000 shares of series C preferred stock into 4,697,368 shares of common stock. On October 22, 2020, the company converted 23,800 shares of series C preferred stock into 6,754,054 shares of common stock. On October 29, 2020, the company converted $10,000 of principal and $2,072 of interest of the GS Capital Convertible Note into 4,432,759 shares of common stock. On October 21, 2020, both the Master Lease and Sublease agreements at Elizabeth St were terminated. The termination of the Lease, and the obligations of Lessee thereunder, is subject to, and conditioned upon, Westward Summit, LLC, a Colorado limited liability company, whose address is 4242 Elizabeth Street, Denver, Colorado 80216 (as “Tenant”), Royal Asset Management, LLC, a Colorado limited liability company (as “Guarantor”), and Venture Product Consulting, LLC, a Colorado limited liability company (as “Guarantor”), entering into a present, valid, unconditional and fully enforceable Lease and Guaranty Agreement with Lessor for the Premises. The date of said Lease and Guaranty Agreement shall be the “Lease Termination Date” of the Lease which is the subject of this Agreement. Upon the Lease Termination Date, and in consideration of the Recitals, covenants, agreements, representations and warranties contained herein, the Lease shall be terminated and canceled and the term thereof is brought to an end as of said Lease Termination Date, with the same force and effect as if the term of said Lease was, by the terms and provisions thereof, fixed to expire on said Lease Termination Date, except as otherwise provided herein. Until said Lease Termination Date Lessee shall remain fully obligated and liable to Lessor for all obligations, covenants, warranties and conditions under the Lease. Per the termination agreement dated October 21, 2020 the Lessor was to return the $120,000.00 security deposit and prepaid rent to Lessee, plus a $55,000 commission for the releasing of the facility to Westward Summit, LLC, less $38,558 of deferred rents owed by the Lessee to Lessor from June 2017 through August 2017, for a total of $136,442. As of the date of this report, no such transactions have occurred. No settlement payments were exchanged in the termination of the master and sublease agreements. On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency in response to a new strain of a coronavirus (the “COVID-19 outbreak”). In March 2020, the WHO classified the COVID-19 outbreak as a pandemic based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve as of the date of this report. Management is actively monitoring the global situation and its effects on the Company’s industry, financial condition, liquidity, and operations. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for fiscal year 2020. However, if the pandemic continues, it may have a material adverse effect on the Company’s results of future operations, financial position, and liquidity in fiscal year 2020.

Significant and Critical Acco_2

Significant and Critical Accounting Policies and Practices (Policies)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements and related notes have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and presented in accordance with accounting principles generally accepted in the United States of America (US GAAP). The accompanying consolidated balance sheet at December 31, 2019, has been derived from audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying unaudited condensed consolidated financial statements as of September 30, 2020 and for the nine months ended September 30, 2020 and 2019, have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements, and should be read in conjunction with the audited consolidated financial statements and related notes to the financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 as filed with the U.S. Securities and Exchange Commission (“SEC”) on the opinion of management, all material adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been made to the condensed consolidated financial statements. The condensed consolidated financial statements include all material adjustments (consisting of normal recurring accruals) necessary to make the condensed consolidated financial statements not misleading as required by Regulation S-X Rule 10-01. Operating results for the nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020 or any future periods.
Principles of Consolidation	Principles of Consolidation The financial statements include the accounts of Diego Pellicer Worldwide, Inc., and its wholly-owned subsidiary Diego Pellicer World-wide 1, Inc. Intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include valuing equity securities and derivative financial instruments issued in financing transactions and share based payment arrangements, the collectability of accounts receivable and other receivables (See Note 5), valuation of right of use assets and lease liabilities and deferred taxes and related valuation allowances. Certain estimates, including evaluating the collectability of accounts receivable, could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could influence our estimates that could cause actual results to differ from our estimates. The Company intends to re-evaluate all its accounting estimates at least quarterly based on these conditions and record adjustments when necessary.
Fair Value Measurements	Fair Value Measurements The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Fair Value of Financial Instruments	Fair Value of Financial Instruments As required by the Fair Value Measurements and Disclosures Topic of the FASB ASC, fair value is measured based on a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity). Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of September 30, 2020 and December 31, 2019. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values. These financial instruments include cash, prepaid expenses and accounts payable. Fair values were assumed to approximate carrying values for cash and payables because they are short term in nature and their carrying amounts approximate fair values or they are payable on demand. The following table reflects assets and liabilities that are measured at fair value on a recurring basis (in thousands): As of September 30, 2020 Fair Value Measurement Using Level 1 Level 2 Level 3 Total Derivative liabilities $ — $ — $ 4,078 $ 4,078 Stock warrant liabilities — — 1 1 $ — $ — $ 4,786 $ 4,786 As of December 31, 2019 Fair Value Measurement Using Level 1 Level 2 Level 3 Total Derivative Liabilities $ — $ — $ 5,024 $ 5,024 Stock warrant Liabilities — — 1 1 $ — $ — $ 5,025 $ 5,025 Derivative liabilities and stock warrant liabilities were valued using the Binomial Option Pricing Model in calculating the embedded conversion features for the nine months ended September 30, 2020 and the year ended December 31, 2019.
Cash	Cash The Company maintains cash balances at various financial institutions. Accounts at each institution are insured by the Federal Deposit Insurance Corporation, and the National Credit Union Share Insurance Fund, up to $250,000. The Company’s accounts at these institutions may, at times, exceed the federal insured limits. The Company has not experienced any losses in such accounts.
Revenue Recognition	Revenue recognition In accordance with ASC 842, Leases During the initial term of the lease, management has a policy of partial rent forbearance when the tenant first opens the facility to assure that the tenant has the opportunity for success. Management may be required to exercise considerable judgment in estimating revenue to be recognized. When management concludes that the Company is the owner of tenant improvements, management records the cost to construct the tenant improvements as a capital asset. In addition, management records the cost of certain tenant improvements paid for or reimbursed by tenants as capital assets when management concludes that the Company is the owner of such tenant improvements. For these tenant improvements, management records the amount funded or reimbursed by tenants as deferred revenue, which is amortized as additional rental income over the term of the related lease. When management concludes that the tenant is the owner of tenant improvements for accounting purposes, management records the Company’s contribution towards those improvements as a lease incentive, which is amortized as a reduction to rental revenue on a straight-line basis over the term of the lease. The Company has adopted the new revenue recognition guidelines in accordance with ASC 606, Revenue from Contracts with Customers Leases. The Company analyzes its contracts to assess that they are within the scope and in accordance with ASC 606. In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under each of its agreements, whether for goods and services or licensing, the Company performs the following steps: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations based on estimated selling prices; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.
Advertising	Advertising During the nine months ended September 30, 2020 and 2019, advertising expense was $24,593 and $42,406, respectively.
Income Taxes	Income Taxes Income taxes are provided for using the liability method of accounting in accordance with the Income Taxes Topic of the FASB ASC. Deferred tax assets and liabilities are determined based on differences between the financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized and when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The computation of limitations relating to the amount of such tax assets, and the determination of appropriate valuation allowances relating to the realizing of such assets, are inherently complex and require the exercise of judgment. As additional information becomes available, the Company continually assesses the carrying value of their net deferred tax assets.
Common Stock Purchase Warrants and Other Derivative Financial Instruments	Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide us a choice of net cash settlement or settlement in our own shares (physical settlement or net-share settlement) provided that such contracts are indexed to our own stock as defined in ASC Topic 815-40 “Contracts in Entity’s Own Equity.” The Company classifies as assets or liabilities any contracts that require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside our control or give the counterparty a choice of net-cash settlement or settlement in shares. The Company assesses classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.
Stock-Based Compensation	Stock-Based Compensation The Company recognizes compensation expense for stock-based compensation in accordance with ASC Topic 718. The Company calculates the fair value of the award on the date of grant using the Black-Scholes method for stock options and the quoted price of our common stock for unrestricted shares; the expense is recognized over the service period for awards expected to vest. The estimation of stock-based awards that will ultimately vest requires judgment, and to the extent actual results or updated estimates differ from original estimates, such amounts are recorded as a cumulative adjustment in the period estimates are revised. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience. The adoption of new standard did not have a material impact on the Company’s Consolidated Financial Statements.
Income (loss) per common share	Income (loss) per common share The Company utilizes ASC 260, “Earnings per Share” for calculating the basic and diluted loss per share. In accordance with ASC 260, the basic and diluted loss per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding. Diluted net loss per share is computed similar to basic loss per share except that the denominator is adjusted for the potential dilution that could occur if stock options, warrants, and other convertible securities were exercised or converted into common stock. Potentially dilutive securities are not included in the calculation of the diluted loss per share if their effect would be anti-dilutive. The Company has 1,129,526,612 and 533,059,641 common stock equivalents at September 30, 2020 and 2019, respectively. For the nine and three months ended September 30, 2020, the potential shares were excluded from the shares used to calculate diluted earnings per share as their inclusion would reduce net loss per share. There are 840,000,000 shares authorized resulting in 289,076,612 insufficient shares as of September 30, 2020.
Legal and Regulatory Environment	Legal and regulatory environment The cannabis industry is subject to numerous laws and regulations of federal, state and local governments. These laws and regulations include, but are not limited to, matters such as licensure, accreditation, and different taxation between federal and state. Federal government activity may increase in the future with respect to companies involved in the cannabis industry concerning possible violations of federal statutes and regulations. Management believes that the Company is in compliance with local, state and federal regulations, while no regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation, as well as regulatory actions unknown or unasserted at this time.

Organization and Operations (Ta

Organization and Operations (Tables)	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of properties generating rents	The properties generating rents in 2019 and 2020 are as follows: Purpose Size City State Retail store (recreational and medical) 3,300 sq. Denver CO Cultivation warehouse 18,600 sq. Denver CO Cultivation warehouse 14,800 sq. Denver CO Retail store (recreational and medical) - Sold in May 2019 4,500 sq. Seattle WA

Significant and Critical Acco_3

Significant and Critical Accounting Policies and Practices (Tables)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Schedule of fair value, assets and liabilities measured on recurring basis	The following table reflects assets and liabilities that are measured at fair value on a recurring basis (in thousands): As of September 30, 2020 Fair Value Measurement Using Level 1 Level 2 Level 3 Total Derivative liabilities $ — $ — $ 4,078 $ 4,078 Stock warrant liabilities — — 1 1 $ — $ — $ 4,786 $ 4,786 As of December 31, 2019 Fair Value Measurement Using Level 1 Level 2 Level 3 Total Derivative Liabilities $ — $ — $ 5,024 $ 5,024 Stock warrant Liabilities — — 1 1 $ — $ — $ 5,025 $ 5,025

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2020
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	As of September 30, 2020 and December 31, 2019, fixed assets and the estimated lives used in the computation of depreciation are as follows: Estimated Useful September 30, December 31, Lives 2020 2019 Leasehold improvements 10 years 515,450 515,450 Less: Accumulated depreciation and amortization (515,450 ) (515,450 ) Property and equipment, net $ — $ —

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Schedule of Liabilities Measured Using Fair Significant Unobservable Inputs (Level 3)	The tables below provides the note payable activity for the nine months ended September 30, 2020, and the nine months ended September 30, 2019, and also a reconciliation of the beginning and ending balances for the derivative liabilities measured using fair significant unobservable inputs (Level 3) for the nine months ended September 30, 2020 and for the nine months ended September 30, 2019: Convertible Notes Discount Convertible Notes, Net of Discount Derivative Liabilities Balance, December 31, 2019 $ 3,266,775 $ 914,239 $ 2,352,530 $ 4,834,190 Issuance of convertible notes 103,000 103,000 — 394,001 Conversion of convertible notes (119,000 ) (39,843 ) (79,157 ) (128,583 ) Repayment of convertible notes (7,500 ) — (7,500 ) — Change in fair value of derivatives — — — (1,084,517 ) Amortization — (942,602 ) 942,601 — Balance September 30, 2020 $ 3,243,275 $ 34,794 $ 3,208,474 $ 4,015,091 Convertible Notes Discount Convertible Notes, Net of Discount Derivative Liabilities Balance, December 31, 2018 $ 3,324,487 $ 2,151,167 $ 1,173,319 $ 6,000,830 Issuance of convertible notes 870,500 886,725 (16,225 ) 1,656,840 Conversion of convertible notes (767,533 ) (210,217 ) (557,316 ) (835,725 ) Repayment of convertible notes (122,500 ) — (120,500 ) (56,197 ) Change in fair value of derivatives — — — (1,873,119 ) Amortization — (1,409,516 ) 1,409,516 — Balance September 30, 2019 $ 3,306,954 $ 1,418,159 $ 1,888,795 $ 4,892,629
Schedule of Assumptions Used Black Scholes Model	The following assumptions were used in the Binomial Option Pricing Model in calculating the embedded conversion features and current liabilities for the nine months ended September 30, 2020 and 2019. September 30, September 30, Risk-free interest rates 0.10-0.11% 1.92% Expected life (years) 0.25 – 0.50 0.08 – 1.25 Expected dividends 0% 0% Expected volatility 147 - 165% 70 - 557%

Stockholder's Equity (Deficit)

Stockholder's Equity (Deficit) (Tables)	9 Months Ended
	Sep. 30, 2020
Equity [Abstract]
Schedule of stock	Preferred Stock and Accrued Dividends Discount Preferred Stock and Accrued Dividends, Net of Discount Derivative Liabilities Balance, December 31, 2019 $ 140,000 $ 131,250 $ 8,750 $ 190,131 Issuance of Series C Preferred shares 111,600 111,600 — 170,896 Conversion of Series C Preferred shares and accrued dividend (206,561 ) (132,768 ) (73,793 ) (302,127 ) Accretion of conversion feature on Series C preferred stock 13,345 (67,200 ) 80,545 15,610 Change in fair value of derivatives — — — (11,304 ) Balance September 30, 2020 $ 58,324 $ 42,882 $ 15,502 $ 63,206
Schedule of assumptions	The following assumptions were used in the Binomial Option Pricing Model in calculating the embedded conversion features and current liabilities for the three months ended September 30, 2020 and the year ended December 31, 2019. September 30, September 30, Risk-free interest rates 0.12 – 0.14% 1.53 – 2.60% Expected life (years) 1.2 – 1.54 0.08 – 1.25 Expected dividends 0% 0% Expected volatility 171.7 – 180.1% 70 - 557%
Schedule of Warrant Liabilities Measured using Fair Significant Unobservable Inputs (Level 3)	The table below provides a reconciliation of the beginning and ending balances for the warrant liabilities measured using fair significant unobservable inputs (Level 3) for the nine months ended September 30, 2020: Balance at December 31, 2019 $ 967 Issuance of warrants — Change in fair value during period 334 Balance at September 30, 2020 $ 633
Schedule of Fair Value on Assumptions	The following assumptions were used in calculations of the Binomial Option Pricing Model for the periods ended September 30, 2020 and the year ended December 31, 2019. September 30, December 31, Annual dividend yield 0% 0% Expected life (years) 0.17-7.13 0.42 – 8.13 Risk-free interest rate 0.11 – 0.55% 1.56 – 2.40% Expected volatility 234.4 - 239.7% 165 - 318%
Schedule of stock warrant activity	The following represents a summary of all common stock warrant activity: Number of Weighted Average Weighted Average Balance outstanding, December 31, 2019 211,826 $ 10.08 3.51 Expired (78,031 ) $ 30.00 - Balance outstanding, September 30, 2020 133,795 $ 10.08 3.22 Exercisable, September 30, 2020 133,795 $ 10.08 3.22
Schedule of Stock Option Activity	The following represents a summary of all common stock option activity: Number of Weighted Average Weighted Average Balance outstanding, December 31, 2019 172,479 $ 5.29 5.47 Granted — — Balance outstanding, September 30, 2020 172,479 $ 5.25 5.22 Exercisable, September 30, 2020 172,479 $ 5.25 5.22

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Schedule of maturities of operating leases liabilities	As of September 30, 2020, the maturities of operating leases liabilities are as follows (in thousands): Operating Leases 2020 remaining $ 241 2021 863 2022 719 2023 733 2024 445 2025 and beyond 45 Total 3,046 Less: amount representing interest (576 ) Present value of future minimum lease payments 2,470 Less: current obligations under leases 678 Long-term lease obligations $ 1,793
Schedule of rent expense is recognized on a straight-line basis	Rent expense is recognized on a straight-line basis over the life of the lease. Rent expense consists of the following: Nine months ended September 30, Operating lease costs $ 508,199 Variable rent costs 349,336 Total rent expense $ 857,535
Schedule of other information related to leases	Other information related to leases is as follows: Nine months ended September 30, Other information: Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 118,577 Weighted-average remaining lease term - operating leases 3.64 yr Weighted-average discount rate - operating leases 12 %
Sublease income	As of September 30, 2020, the maturities of expected base sublease income are as follows (in thousands): Operating Leases Remaining of 2020 $ 328 2021 1,154 2022 930 2023 944 2024 588 2025 and beyond 58 Total $ 4,002
Schedule of accrued compensation expenses	During the three and nine months ending September 30, 2020 and 2019, the Company accrued compensation expenses as follows: Three Months ending September 30, Three Months ending September 30, Nine Months ending September 30, Nine Months ending September 30, Compensation $ 46,092 $ 224,941 $ 92,034 $ 539,957 Number of Shares 4,216,438 6,518,625 6,461,325 15,233,729

Organization and Operations (De

Organization and Operations (Details)	9 Months Ended
	Sep. 30, 2020ft²
State	DE
Retail store (recreational and medical)
Area	3,300
City	Denver
State	CO
Cultivation warehouse
Area	18,600
City	Denver
State	CO
Cultivation warehouse
Area	14,800
City	Denver
State	CO
Retail store (recreational and medical) - Sold
Area	4,500
City	Seattle
State	WA

Organization and Operations (_2

Organization and Operations (Details Narrative) - Type 1 Media, Inc [Member]	9 Months Ended
	Sep. 30, 2020USD ($)shares
Number of shares issued and outstanding prior merger	3,135,000
Number of shares agreed to issued and outstanding by principal owner | $	$ 2,750,000
Consideration for agreed shares | $	$ 169,000
Number of shares cancellation during the period	2,750,000
Exchanged for right to receive share	1
Stock issued during period convertible securities	1,081,613
Percentage of combined entity	74.00%

Significant and Critical Acco_4

Significant and Critical Accounting Policies and Practices (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Derivative liabilities	$ 4,078	$ 5,024
Stock warrant liabilities	1	1
Total	4,786	5,025
Level 1 [Member]
Derivative liabilities
Stock warrant liabilities
Total
Level 2 [Member]
Derivative liabilities
Stock warrant liabilities
Total
Level 3 [Member]
Derivative liabilities	4,078	5,024
Stock warrant liabilities	1	1
Total	$ 4,786	$ 5,025

Significant and Critical Acco_5

Significant and Critical Accounting Policies and Practices (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Common stock equivalents	1,129,526,612	533,059,641
Advertising expense	$ 24,593	$ 42,406
Shares authorized	840,000,000		840,000,000
Insufficient shares	289,076,612
Maximum [Member]
Cash insured by FDIC	$ 250,000

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Working capital deficit	$ (10,235,550)
Accumulated deficit	$ (53,088,078)	$ (51,968,902)

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Leasehold Improvements	$ 515,450	$ 515,450
Less: Accumulated depreciation and amortization	(515,450)	(515,450)
Property and equipment, net
Leasehold Improvements [Member]
Property and Equipment Estimated Useful Lives	10 years

Property and Equipment (Detai_2

Property and Equipment (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Property, Plant and Equipment [Abstract]
Depreciation expense				$ 139,595

Accounts Receivables and Othe_2

Accounts Receivables and Other Receivables (Details Narrative) - USD ($)	1 Months Ended		9 Months Ended
	Feb. 27, 2020	Nov. 02, 2018	Sep. 30, 2020	Sep. 09, 2020	Dec. 31, 2019
Notes receivable			$ 1,259,247		$ 1,017,143
Accrued interest receivable			219,201		153,509
Leasing hold improvement paid			228,966		228,966
Receivables guaranteed			400,000
Other receivables			753,331		$ 788,177
Receivables from subleases			498,630
Proceeds from loan			$ 242,104
Membership Interest Purchase Agreement [Member]
Ownership percentage				15.13%
Membership Interest Purchase Agreement [Member] | E2T2, LLC [Member]
Proceeds from receivables	$ 50,000	$ 300,000
Payment to related party debt	$ 34,265
Minimum [Member]
Interest rate			12.00%
Maximum [Member]
Interest rate			18.00%
Third Parties [Member]
Other Receivables			$ 1,030,000

Other Assets (Details Narrative

Other Assets (Details Narrative) - USD ($)	May 06, 2019	Sep. 30, 2020	Dec. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Security deposits		$ 150,000	$ 150,000
Settlement of security deposit	$ 20,000
Deposits - end of lease		$ 0	$ 0

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	Sep. 30, 2016
Accrued fees - related parties	$ 280,097		$ 280,097		$ 155,841
Accrued payable	1,071,311		1,071,311		1,137,397
Cash based compensation - related parties	90,000	$ 122,099	270,000	$ 379,597
Share based compensation - related parties	86,687	136,616	213,714	661,742
Gross revenues	67,586	$ 107,605	222,847	$ 399,119
Notes payable related parties	140,958		$ 140,958		140,958
Related party description			From 2017 to 2019, Mr . Gonfiantini, CEO, personally and through his Company, Crystal Bay Financial LLC, loaned an aggregate amount of $1,020,000 to Royal Asset Management. These notes accrue interest at 17%-18% per annum, and require monthly payment approximately from $5,000 to $20,000. These notes are personally guaranteed by the managing member of Royal Asset Management, and secured by certain equipment and other tangible properties of Royal Asset Management. Among these notes, $500,000 note was also secured by the medical marijuana licenses held by Royal Asset Management.
Mr. Throgmartin [Member]
Accrued interest						$ 1,480,000
Debt instrument face amount	$ 140,958		$ 140,958
Debt instrument interest rate	8.00%		8.00%
Gross revenues			$ 3,000,000
Stock Payable [Member]
Accrued fees - related parties	$ 94,060		$ 94,060		$ 5,245

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	Apr. 02, 2018	Jul. 02, 2020	Jun. 30, 2020	Apr. 22, 2020	Sep. 30, 2020	Dec. 31, 2019	Aug. 31, 2015
Note maturity date	Oct. 31, 2018
Note payable					$ 339,847	$ 133,403
Proceeds from loan					$ 242,104
Numerica Credit Union [Member]
Proceeds from loan				$ 56,444
Interest rate				1.00%
Small Business Association [Member]
Proceeds from loan		$ 149,900	$ 150,000
Interest rate		3.75%
Third Parties [Member]
Note payable principal amount							$ 126,000

Convertible Notes Payable (Deta

Convertible Notes Payable (Details) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Issuance of convertible notes	$ 100,000	$ 862,725
Repayment of convertible notes	(7,500)	(120,500)
Convertible Debt [Member]
Balance, beginning	3,266,775	3,324,487
Issuance of convertible notes	103,000	870,500
Conversion of convertible notes	(119,000)	(767,533)
Repayment of convertible notes	(7,500)	(122,500)
Change in fair value of derivatives
Amortization
Balance, ending	3,243,275	3,306,954
Discount [Member]
Balance, beginning	914,239	2,151,167
Issuance of convertible notes	103,000	886,725
Conversion of convertible notes	(39,843)	(210,217)
Repayment of convertible notes
Change in fair value of derivatives
Amortization	(942,602)	(1,409,516)
Balance, ending	34,794	1,418,159
Convertible Note Net of Discount [Member]
Balance, beginning	2,352,530	1,173,319
Issuance of convertible notes		(16,225)
Conversion of convertible notes	(79,157)	(557,316)
Repayment of convertible notes	(7,500)	(120,500)
Change in fair value of derivatives
Amortization	942,601	1,409,516
Balance, ending	3,208,474	1,888,795
Derivative Liabilities [Member]
Balance, beginning	4,834,190	6,000,830
Issuance of convertible notes	394,001	1,656,840
Conversion of convertible notes	(128,583)	(835,725)
Repayment of convertible notes		(56,197)
Change in fair value of derivatives	(1,084,517)	(1,873,119)
Amortization
Balance, ending	$ 4,015,091	$ 4,892,629

Convertible Notes Payable (De_2

Convertible Notes Payable (Details 1)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Expected Dividends [Member]
Fair value assumptions, percentage	0.00%	0.00%
Minimum [Member] | Risk Free Interest Rates [Member]
Fair value assumptions, percentage	0.10%	1.92%
Minimum [Member] | Expected Life [Member]
Fair value assumptions, term	2 months 30 days	29 days
Minimum [Member] | Expected Volatility [Member]
Fair value assumptions, percentage	147.00%	70.00%
Maximum [Member] | Risk Free Interest Rates [Member]
Fair value assumptions, percentage	0.11%	1.92%
Maximum [Member] | Expected Life [Member]
Fair value assumptions, term	6 months	1 year 2 months 30 days
Maximum [Member] | Expected Volatility [Member]
Fair value assumptions, percentage	165.00%	557.00%

Convertible Notes Payable (De_3

Convertible Notes Payable (Details Narrative) - USD ($)	1 Months Ended			9 Months Ended
	Sep. 28, 2020	Mar. 29, 2019	Jul. 17, 2018	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Derivative liability				$ 4,015,091		$ 4,834,190
Common stock issued				164,591,275		113,926,332
Gain on extinguishment of debt				$ 1,255	$ 218,196
Proceeds from loan				242,104
Financing costs					2,892,033
Convertible notes past due				3,175,275
Black Sholes Merton Option Model [Member]
Loan				700,000
Proceeds from loan		$ 100,000		380,000
Financing costs				206,710
Debt discount				380,000
Convertible notes past due		$ 154,861		586,710
Equity and Debt Restructure Agreement [Member] | Second Investors [Member]
Principal amount			$ 545,607
Equity and Debt Restructure Agreement [Member] | First Investors [Member]
Principal amount			1,683,558
Loan			700,000
Proceeds from loan			$ 220,000
Equity and Debt Restructure Agreement [Member] | Investors [Member]
Number of restricted common shares cancelled			2,774,093
Fair value of restricted common shares			$ 443,855
Fair value of embedded conversion feature			$ 3,555,888
Several Convertible Notes [Member]
Convertible notes				73,000
Conversion of convertible notes	$ 30,000			103,000
Accrued interest	$ 2,042			$ 4,968
Debt instruments conversion into shares	5,733,397
Interest rate				12.00%
Gain on extinguishment of debt	$ (1,884)
Fair value of embedded conversion feature				$ 60,362
Extinguishment of debt discount	14,466
Reduction of derivative liabilities	$ 25,485
Holder [Member]
Conversion of convertible notes				119,000	450,212
Accrued interest				8,166	$ 31,345
Additional fee				$ 210
Debt instruments conversion into shares				19,501,028	12,242,678
Gain on extinguishment of debt				$ 1,931	$ 130,031
Repayment of debt				7,500
Accrued interest repaid				819
Extinguishment of debt discount				39,843
Reduction of derivative liabilities				$ 128,583

Stockholder's Equity (Deficit_2

Stockholder's Equity (Deficit) (Details)	9 Months Ended
	Sep. 30, 2020USD ($)
Preferred Stock and Accrued Dividends [Member]
Balance at beginning	$ 140,000
Issuance of Series C Preferred shares	111,600
Conversion of Series C Preferred shares	(206,561)
Conversion of Series C Preferred shares and accrued dividend
Accretion of conversion feature on Series C preferred stock	13,345
Change in fair value of derivatives
Balance at end	58,324
Preferred Stock and Accrued Dividends Net of Discount [Member]
Balance at beginning	8,750
Issuance of Series C Preferred shares
Conversion of Series C Preferred shares	(73,793)
Conversion of Series C Preferred shares and accrued dividend
Accretion of conversion feature on Series C preferred stock	80,545
Change in fair value of derivatives
Balance at end	15,502
Discount [Member]
Balance at beginning	131,250
Issuance of Series C Preferred shares	111,600
Conversion of Series C Preferred shares	(132,768)
Conversion of Series C Preferred shares and accrued dividend
Accretion of conversion feature on Series C preferred stock	(67,200)
Change in fair value of derivatives
Balance at end	42,882
Derivative Liabilities [Member]
Balance at beginning	190,131
Issuance of Series C Preferred shares	170,896
Conversion of Series C Preferred shares	(302,761)
Conversion of Series C Preferred shares and accrued dividend
Accretion of conversion feature on Series C preferred stock	15,610
Change in fair value of derivatives	(11,304)
Balance at end	$ 62,572

Stockholder's Equity (Deficit_3

Stockholder's Equity (Deficit) (Details 1)	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Expected dividends	0.00%	0.00%
Minimum [Member]
Risk-free interest rate	0.12%	1.53%
Expected life (years)	1 year 5 months 12 days	29 days
Expected volatility	171.70%	70.00%
Maximum [Member]
Risk-free interest rate	0.14%	2.60%
Expected life (years)	1 year 6 months 14 days	1 year 2 months 30 days
Expected volatility	180.10%	557.00%

Stockholder's Equity (Deficit_4

Stockholder's Equity (Deficit) (Details 2) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Change in fair value during period	$ (362)	$ (1,038)	$ (334)	$ (15,114)
Level 3 [Member]
Balance at beginning			967
Issuance of warrants
Change in fair value during period			334
Balance at end	$ 633		$ 633

Stockholder's Equity (Deficit_5

Stockholder's Equity (Deficit) (Details 3)	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Annual dividend yield	0.00%	0.00%
Minimum [Member]
Expected life (years)	2 months 1 day	5 months 1 day
Risk-free interest rate	0.11%	1.56%
Expected volatility	234.40%	165.00%
Maximum [Member]
Expected life (years)	7 years 1 month 16 days	8 years 1 month 16 days
Risk-free interest rate	0.55%	2.40%
Expected volatility	239.70%	318.00%

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit) (Details 4) - $ / shares	9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Weighted Average Exercise Price, Beginning balance	$ 5.29
Weighted Average Exercise Price, Ending balance	5.25		$ 5.29
Weighted Average Exercise Price, Exercisable ending balance	$ 5.25
Weighted Average Remaining Contractual Term	5 years 2 months 19 days	5 years 5 months 20 days
Weighted Average Remaining Contractual Term, Exercisable ending balance	5 years 2 months 19 days
Warrant [Member]
Number of warrant, Beginning balance	211,826
Number of warrant, Forfeited	(78,031)
Number of warrant, Ending balance	133,795		211,826
Number of warrant,Exercisable ending balance	133,795
Weighted Average Exercise Price, Beginning balance	$ 10.08
Weighted Average Exercise Price, Forfeited	30
Weighted Average Exercise Price, Ending balance	10.08		$ 10.08
Weighted Average Exercise Price, Exercisable ending balance	$ 10.08
Weighted Average Remaining Contractual Term	3 years 2 months 19 days		3 years 6 months 3 days
Weighted Average Remaining Contractual Term, Exercisable ending balance	3 years 2 months 19 days

Stockholders' Equity (Deficit_2

Stockholders' Equity (Deficit) (Details 5) - $ / shares	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Equity [Abstract]
Number of Options, Beginning balance	172,479
Number of Options, Granted
Number of Options, Ending balance	172,479
Number of Options, Exercisable ending balance	172,479
Weighted Average Exercise Price, Beginning balance	$ 5.29
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Ending balance	5.25
Weighted Average Exercise Price, Exercisable ending balance	$ 5.25
Weighted Average Remaining Contractual Term	5 years 2 months 19 days	5 years 5 months 20 days
Weighted Average Remaining Contractual Term, Exercisable ending balance	5 years 2 months 19 days

Stockholder's Equity (Deficit_6

Stockholder's Equity (Deficit) (Details Narrative) - USD ($)	Aug. 11, 2020	Aug. 05, 2020	Apr. 14, 2020	Aug. 17, 2020	Jul. 30, 2020	Jul. 21, 2020	Jun. 16, 2020	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Derivative liability								$ 4,078		$ 5,024
Shares available for future grants								35,250
Stock option expenses								$ 121,785
Unamortized stock option								5,416
Intrinsic value of stock options outstanding								$ 0
Reserved for issuance								124,000
Shares granted								88,750
Common Stock payable issued for services - related parties								$ 65,633
Common Stock payable issued for services - related parties, shares								2,553,969
Unissued shares for related party, shares								3,907,356
Unissued shares for related party, value								$ 28,296
Holder [Member]
Number of shares issued for conversion of notes, value								$ 119,000	$ 450,212
Debt converted into share								19,501,028	12,242,678
Accrued interest								$ 8,166	$ 31,345
Additional fee								210
Extinguishment of debt discount								39,843
Reduction of derivative liabilities								$ 128,583
Series C Preferred Stock [Member]
Preferred stock, shares outstanding								55,800		140,000
Derivative liability								$ 88,868		$ 165,218
Conversion feature								75,652		190,131
Accretion of discount								9,096		8,750
Accrued dividend								1,819
Discount								$ 46,704		$ 131,250
Debt converted into share	20,000	15,000		20,000	20,000	20,000		63,403
Number of common stock issued	3,387,097	2,423,077		3,442,623	3,181,818	1,800,000		5,196,378
Shares conversion description							39,048 shares of Series C Preferred Stock along with related discount of $26,872 were converted to 4,939,759 shares of Common Stock per the terms of the Agreement.
Common Stock payable issued for services - related parties								$ 32,343,343
Common Stock payable issued for services - related parties, shares								195,800
Preferred stock, converted shares								55,800
Series C Preferred Stock [Member] | Geneva [Member]
Preferred stock, shares outstanding								0
Derivative liability								$ 59,803
Series C Preferred Stock [Member] | Geneva [Member]
Preferred stock, shares outstanding								55,800
Derivative liability			$ 63,206
Accretion of discount								$ 67,201
Accrued dividend								2,583
Discount								$ 42,882
Sale of stock			55,800
Preferred stock, converted shares								140,000
Redeemable convertible preferred stock, Series C [Member]
Preferred stock, shares outstanding								100,952
Conversion feature								$ 116,880
Accretion of discount								34,904
Accrued dividend								2,583
Discount								$ 69,474

Commitments and Contingencies_2

Commitments and Contingencies (Details)	Sep. 30, 2020USD ($)
Commitments and Contingencies Disclosure [Abstract]
2020 remaining	$ 241,000
2021	863,000
2022	719,000
2023	733,000
2024	445,000
2025 and beyond	45,000
Total	3,046,000
Less: amount representing interest	(576,000)
Present value of future minimum lease payments	2,470,000
Less: current obligations under leases	678,000
Long-term lease obligations	$ 1,793,000

Commitments and Contingencies_3

Commitments and Contingencies (Details 1)	9 Months Ended
	Sep. 30, 2020USD ($)
Commitments and Contingencies Disclosure [Abstract]
Operating lease costs	$ 508,199
Variable rent costs	349,336
Total rent expense	$ 857,535

Commitments and Contingencies_4

Commitments and Contingencies (Details 2)	9 Months Ended
	Sep. 30, 2020USD ($)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 118,577
Weighted-average remaining lease term - operating leases	3 years 7 months 21 days
Weighted-average discount rate - operating leases	12.00%

Commitments and Contingencies_5

Commitments and Contingencies (Details 3)	Sep. 30, 2020USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remaining of 2020	$ 328,000
2021	1,154,000
2022	930,000
2023	944,000
2024	588,000
2025 and beyond	58,000
Total	$ 4,002,000

Commitments and Contingencies_6

Commitments and Contingencies (Details 4) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
Compensation	$ 46,092	$ 224,941	$ 92,034	$ 539,957
Number of Shares	4,216,438	6,518,625	6,461,325	15,233,729

Commitments and Contingencies_7

Commitments and Contingencies (Details Narrative) - USD ($)	Feb. 01, 2019	Oct. 29, 2019	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Operating leases discount rate			12.00%		12.00%
Weighted-average remaining lease term			3 years 7 months 21 days		3 years 7 months 21 days
Sublease income					$ 1,080,382	$ 1,257,255
Stock issued for employment agreements					$ 92,034		$ 593,000
Stock issued for employment agreements, Shares					6,461,325		20,782,014
Accrued compensation			$ 60,022		$ 60,022		$ 79,817
Proceeds from deposits					120,000
Sublease payment			1,325,443		1,325,443
COLORADO
Sublease income					$ 2,139,000
Colorado [Member] | Minimum [Member]
Lease term					3 years
Colorado [Member] | Maximum [Member]
Lease term					5 years
Employment Agreements [Member] | Ron Throgmartin
Term		5 years
Accrued salary		$ 5,000
Diem fee		$ 500
Debt description		Company acknowledged it owed Mr. Throgmartin the amount of $517,252.06 in principal and accrued interest of note payable, salary and fees, accrued during the 5 years of his employment. In addition, the Corporation further acknowledged that it will pay Mr Throgmartin fifty (50%) percent of his compensation due under the remaining Employment Agreement, or $614,583.33 under certain condition, which the Company accrued in full as the date of Mr Throgmartin’s separation.
CEO [Member]
Stock grant for restricted common shares for accrued salary	53,717
Restricted common share issued for stock option	122,934
Payment of compensation			13,452	$ 0	$ 21,086	$ 0
Accrued compensation			175,714		175,714		196,800
Outstanding balance			$ 915,597		$ 915,597		$ 940,597
CEO [Member] | Employment Agreements [Member]
Ownership percentage			10.00%		10.00%
Other Executives [Member] | Employment Agreements [Member]
Ownership percentage			2.00%		2.00%

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Oct. 14, 2020	Oct. 12, 2020	Oct. 02, 2020	Oct. 29, 2020	Oct. 22, 2020	Oct. 21, 2020	Sep. 30, 2020
Lease, description							October 21, 2020 the Lessor was to return the $120,000.00 security deposit and prepaid rent to Lessee, plus a $55,000 commission for the releasing of the facility to Westward Summit, LLC, less $38,558 of deferred rents owed by the Lessee to Lessor from June 2017 through August 2017, for a total of $136,442.
Subsequent Event [Member]
Number of common stock issued	3,841,463	8,345,908			6,754,054	4,697,368
Debt conversion amount		$ 30,922
Number of preferred stock converted	15,000				23,800	17,000
Common stock shares issued			5,769,230
Subsequent Event [Member] | GS Capital Convertible Note [Member]
Number of common stock issued				4,432,759
Debt conversion amount				$ 10,000
Debt conversion, accrued interest				$ 2,072